---
layout: post
title: "CRO概念股持续走强"
date: 2022-06-06 10:46:31 +0800
categories: cailianshe
tags: 财联社新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688131" data-code="688131|1|1" data-code2="688131|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688131&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688131_0" data-code="K 688131|1|1" data-code2="K 688131|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p> 皓元医药、阳光诺和、和元生物、药明康德、康龙化成、药石科技、凯莱英、华测检测、美迪西、谱尼测试涨超5%。消息面上，近期药明康德公告称预计2022年第二季度收入仍将实现此前公告的63-65%的增长，公司继续对2022年全年实现收入增长65-70%的目标充满信心。</p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202206062402326255>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)